Factors Influencing the Measurement of Plasma/serum Surfactant Protein D Levels by ELISA

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Nov 4

PMID 25365324

Citations 5

Authors

Preston E Bratcher

Amit Gaggar

Affiliations

Soon will be listed here.

Abstract

Background: Extensive variations in human surfactant protein D (SP-D) levels in circulation as measured by ELISA exist in the published literature. In order to determine the source of these variations, factors influencing the measurement by ELISA were explored.

Materials And Methods: Peripheral blood from healthy individuals was collected into various vacutainers during the same blood draw. Recombinant SP-D was diluted into different matrices and used for a standard curve. Samples were analyzed by capture ELISA using one of two distinct detection antibodies.

Results: The type of matrix had some effects on detection of recombinant SP-D. The type of anticoagulant used and dilution factor had very little effect, except for in plasma collected in EDTA vacutainers. The extent of variation in published values seemed to be due to the ELISA configuration employed, and, in agreement with this, we found that by switching the detection antibody, there was a 50% decrease in the extrapolated SP-D value of serum and plasma samples. Storage of samples resulted in slight changes in measured SP-D levels.

Conclusions: The ELISA configuration employed to measure circulating levels of SP-D has a significant effect on the extrapolated values. In both configurations tested, the use of EDTA as a coagulant resulted in inconsistent values, and we, therefore, suggest the avoidance of this anticoagulant when assaying for SP-D by ELISA. While the demonstrated effects of several factors on measurement of SP-D may not account for all the disparities amongst the previous studies, they stress that variations in methodologies for measuring the same protein can result in very inconsistent results.

Citing Articles

Pulmonary surfactants and the respiratory-renal connection in steroid-sensitive nephrotic syndrome of childhood.

Cara-Fuentes G, Andres-Hernando A, Bauer C, Banks M, Garcia G, Cicerchi C iScience. 2022; 25(8):104694.

PMID: 35847557 PMC: 9284382. DOI: 10.1016/j.isci.2022.104694.

Microproteomics with microfluidic-based cell sorting: Application to 1000 and 100 immune cells.

Kasuga K, Katoh Y, Nagase K, Igarashi K Proteomics. 2017; 17(13-14).

PMID: 28556466 PMC: 5600086. DOI: 10.1002/pmic.201600420.

Evaluation and Validation of the Detection of soluble Triggering Receptor Expressed on Myeloid Cells 1 by Enzyme-linked immunosorbent Assay.

Hasibeder A, Stein P, Brandwijk R, Schild H, Radsak M Sci Rep. 2015; 5:15381.

PMID: 26480887 PMC: 4612298. DOI: 10.1038/srep15381.

Synthesis of Phospholipid-Protein Conjugates as New Antigens for Autoimmune Antibodies.

Maity A, Macaubas C, Mellins E, Astakhova K Molecules. 2015; 20(6):10253-63.

PMID: 26046322 PMC: 6272759. DOI: 10.3390/molecules200610253.

Biomarkers of lung injury in cardiothoracic surgery.

Engels G, van Oeveren W Dis Markers. 2015; 2015:472360.

PMID: 25866435 PMC: 4381722. DOI: 10.1155/2015/472360.

References

Nagae H, Takahashi H, Kuroki Y, Honda Y, Nagata A, Ogasawara Y . Enzyme-linked immunosorbent assay using F(ab')2 fragment for the detection of human pulmonary surfactant protein D in sera. Clin Chim Acta. 1998; 266(2):157-71. DOI: 10.1016/s0009-8981(97)00124-1. View

Ihn H, Asano Y, Kubo M, Yamane K, Jinnin M, Yazawa N . Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease. Rheumatology (Oxford). 2002; 41(11):1268-72. DOI: 10.1093/rheumatology/41.11.1268. View

Al-Salmi Q, Walter J, Colasurdo G, Sockrider M, OBrian Smith E, Takahashi H . Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease. Chest. 2005; 127(1):403-7. DOI: 10.1378/chest.127.1.403. View

Fernandez-Luna A, Gallardo L, Plaza-Carmona M, Garcia-Unanue J, Sanchez-Sanchez J, Felipe J . Respiratory function and changes in lung epithelium biomarkers after a short-training intervention in chlorinated vs. ozone indoor pools. PLoS One. 2013; 8(7):e68447. PMC: 3709909. DOI: 10.1371/journal.pone.0068447. View

Maeda M, Ichiki Y, Aoyama Y, Kitajima Y . Surfactant protein D (SP-D) and systemic scleroderma (SSc). J Dermatol. 2001; 28(9):467-74. DOI: 10.1111/j.1346-8138.2001.tb00013.x. View

Watkins T, Rubenfeld G, Martin T, Nester T, Caldwell E, Billgren J . Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Crit Care Med. 2008; 36(5):1493-9. DOI: 10.1097/CCM.0b013e318170a9ce. View

Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, Chiba H . Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med. 2000; 162(1):258-63. DOI: 10.1164/ajrccm.162.1.9903014. View

Fernandez-Real J, Valdes S, Manco M, Chico B, Botas P, Campo A . Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity. Diabetes Care. 2010; 33(4):847-53. PMC: 2845040. DOI: 10.2337/dc09-0542. View

Hoffmann H, Iversen M, Brandslund I, Sigsgaard T, Omland O, Oxvig C . Plasma C3d levels of young farmers correlate with respirable dust exposure levels during normal work in swine confinement buildings. Ann Agric Environ Med. 2003; 10(1):53-60. View

10.

Takahashi H, Shiratori M, Kanai A, Chiba H, Kuroki Y, Abe S . Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology. 2006; 11 Suppl:S51-4. DOI: 10.1111/j.1440-1843.2006.00809.x. View

11.

Van Miert E, Sardella A, Bernard A . Biomarkers of early respiratory effects in smoking adolescents. Eur Respir J. 2011; 38(6):1287-93. DOI: 10.1183/09031936.00000911. View

12.

Hant F, Ludwicka-Bradley A, Wang H, Li N, Elashoff R, Tashkin D . Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol. 2009; 36(4):773-80. DOI: 10.3899/jrheum.080633. View

13.

Todd D, Marsh M, George A, Henderson N, Barr H, Sebastian S . Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children. Pediatr Crit Care Med. 2009; 11(1):82-91. DOI: 10.1097/PCC.0b013e3181ae5a4c. View

14.

Shakoori T, Sin D, Ghafoor F, Bashir S, Bokhari S . Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease. Dis Markers. 2010; 27(6):287-94. PMC: 3834666. DOI: 10.3233/DMA-2009-0674. View

15.

Engstrom G, Lindberg C, Gerhardsson de Verdier M, Nihlen U, Anderson M, Svartengren M . Blood biomarkers and measures of pulmonary function--a study from the Swedish twin registry. Respir Med. 2012; 106(9):1250-7. DOI: 10.1016/j.rmed.2012.05.004. View

16.

Mutti A, Corradi M, Goldoni M, Vettori M, Bernard A, Apostoli P . Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest. 2006; 129(5):1288-97. PMC: 1472634. DOI: 10.1378/chest.129.5.1288. View

17.

Gil H, Hong J, Park J, Seo Y, Yang J, Lee E . Plasma surfactant D in patients following acute paraquat intoxication. Clin Toxicol (Phila). 2007; 45(5):463-7. DOI: 10.1080/15563650701338138. View

18.

Greene K, King Jr T, Kuroki Y, Bucher-Bartelson B, Hunninghake G, Newman L . Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J. 2002; 19(3):439-46. DOI: 10.1183/09031936.02.00081102. View

19.

Haddam N, Samira S, Dumont X, Taleb A, Haufroid V, Lison D . Lung epithelium injury biomarkers in workers exposed to sulphur dioxide in a non-ferrous smelter. Biomarkers. 2009; 14(5):292-8. DOI: 10.1080/13547500902989088. View

20.

Wutzler S, Lehnert T, Laurer H, Lehnert M, Becker M, Henrich D . Circulating levels of Clara cell protein 16 but not surfactant protein D identify and quantify lung damage in patients with multiple injuries. J Trauma. 2010; 71(2):E31-6. DOI: 10.1097/TA.0b013e3181f6f0b4. View